Clinical Trials Logo

Polyps clinical trials

View clinical trials related to Polyps.

Filter by:

NCT ID: NCT00378378 Completed - Nasal Polyps Clinical Trials

Study of Nasonex® for the Treatment of Nasal Polyps in Pediatric Subjects Between Ages of 6 and Less Than 18 Years Old (P04292)

Start date: July 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of Nasonex® (Mometasone Furoate Nasal Spray(MFNS)) in the treatment of nasal polyps in pediatric subjects between the ages of 6 and less than 18 years old. Safety will be the primary focus of this study.

NCT ID: NCT00339625 Completed - Adenoma Clinical Trials

Polyp Prevention Trial

Start date: June 19, 1991
Phase: Phase 3
Study type: Interventional

The primary objective of the Poly Prevention Trial (PPT) is to determine whether a low fat, high fiber, high vegetable and fruit eating plan will decrease the recurrence of adenomatous polyps of the large bowel. Secondary objectives of the PPT include 1) evaluating the effectiveness of the intervention program with respect to participant achievement of dietary goals; 2) examining the relation of dietary change and biochemical markers in blood; and 3) assessing the impact of the intervention on quality of life indicators.

NCT ID: NCT00332943 Completed - Colorectal Cancer Clinical Trials

MR Colonography With Fecal Tagging. Barium vs. BariumFerumoxsil

Start date: December 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether Barium or BariumFerumoxsil is better for fecal tagging in MR colonography. Patients referred to colonoscopy are offered MR colonography before colonoscopy. Two days before colonography, patients ingest either a contrast agent A (200 ml Barium sulphate solution 1g/ml)) four times a day or a 200 ml contrast agent B (Barium sulfate(25%) and Ferumoxil(75%)) four times a day, which will render fecal masses "invisible" on the following MR colonography. The patients are randomised to either contrast agent A or B. The examinations are evaluated by two independent blinded readers, who will rate the tagging quality of the contrast agents. The quality of tagging will be rated by a Visual Analog Scale (VAS) and Relative contrast (ReCon = Iwall - Ilumen/ Iwall + Ilumen).

NCT ID: NCT00323999 Recruiting - Menorrhagia Clinical Trials

Hysteroscopic Monopolar and Bipolar Resection

Start date: December 2004
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate bipolar equipment versus monopolar, and to see if there is any differences between the two types of bipolar equipment espescially regading both safety and effect.

NCT ID: NCT00272324 Completed - Colorectal Cancer Clinical Trials

Aspirin/Folate Prevention of Large Bowel Polyps

Start date: February 1992
Phase: Phase 2/Phase 3
Study type: Interventional

This is a randomized controlled trial of aspirin and/or folate supplementation for the prevention of the recurrence of neoplastic polyps (adenomas) of the large bowel.

NCT ID: NCT00247923 Completed - Endometrial Cancer Clinical Trials

Endometrial Polyps: Pathophysiology and Clinical Consequences

Start date: October 2005
Phase: N/A
Study type: Interventional

The aim of these studies is to study the natural history, the symptoms of, as well as the effect of hysteroscopic resection of endometrial polyps. Furthermore, another aim is to study new diagnostic techniques to differentiate between malignant and benign endometrial polyps.

NCT ID: NCT00237276 Recruiting - Polyps Clinical Trials

Experience and Enhancement: Improving Colonoscopic Polyp Detection

Start date: October 2005
Phase: N/A
Study type: Interventional

The study looks at 2 hypotheses in 2 patient groups: 1. Are more experienced endoscopists better at detecting subtle lesions (polyps) on the lining of the colon (large bowel) than less experienced endoscopists? 2. Do existing and new techniques that can highlight lesions on the lining of the bowel improve endoscopists ability to spot them? This will be tested using video footage of endoscopies from 2 patient groups: those with a normal colon linig and those with colitis (bowel lining inflamation)

NCT ID: NCT00234650 Completed - Polyps Clinical Trials

Adenoma Detection Rate With Position Change at Colonoscopy

Start date: October 2005
Phase: N/A
Study type: Interventional

The hypothesis to be tested is that position changes during the withdrawal phase of colonoscopy leads to a higher adenoma (polyp) detection rate because of better distension of the colon. Since adenomas are precancerous lesions the enhanced adenoma detection will increase the success of colorectal cancer screening programmes. This study will provide evidence for the value of position changes and encourage endoscopist to adopt position change as a routine in their practice. May 2007: protocol amendment to include additional prospective analysis using High Definition TV (HDTV).

NCT ID: NCT00208793 Completed - Clinical trials for Colorectal Adenomatous Polyps

Calcium and Vitamin D vs Markers of Adenomatous Polyps

CaDvMAP
Start date: May 2005
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test whether calcium and/or vitamin D supplementation favorably affects a set of biomarkers of risk for colon cancer in persons who are at higher than average risk for colon cancer (ie, have already undergone the removal of adenomatous polyps, which are known to be precursors to developing colon cancer).

NCT ID: NCT00153816 Completed - Colorectal Cancer Clinical Trials

Vitamin D/Calcium Polyp Prevention Study

Start date: July 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Extensive experimental and observational data suggest that intake of calcium and of vitamin D exert protective effects on colorectal neoplasia. Building on their previous work, the investigators will investigate the chemopreventive effect of vitamin D in the large bowel, to study whether calcium with vitamin D is more effective than calcium alone, and to confirm their positive finding regarding calcium. The goal of this study is the development of chemopreventive combinations that will reduce risk of colorectal neoplasia sufficiently to permit the lengthening of surveillance intervals in most patients and to clarify important issues regarding the mechanisms of colorectal carcinogenesis and chemoprevention.